According to a recent ruling by an Australian Federal Court, Reckitt Benckiser has misled consumers by marketing identical products for different types of pain. The court has even asked the British form to remove its Nurofen pain relief products from the market.

The court said in a statement that the Nurofen Back pain, Migraine Pain and Tension Headache products were found to be identical, and Reckitt Benckiser was involved in cheating its customers.

A pharmacist at Priceline Pharmacy's Sydney city store told Reuters, “We have known for years that they are all the same. We have been advising our customers to go for the standard painkiller which is cheaper”.

Some specific Nurofen pain relief products were sold at almost double the price of Nurofen's standard painkiller, according to three pharmacies in Sydney.

Australia has become the first country to raise voice against Nurofen specific pain relief products, which are sold in New Zealand and the United Kingdom. Nurofen spokeswoman Montse Pena declined to give any comment on which countries outside Australia sold the specific pain relief versions of Nurofen.

The Australian Competition and Consumer Commission (ACCC), which brought the court action, said on Monday that Reckitt Benckiser has been given a three months time to remove the Nurofen specific pain relief products from Australian market.

Pena said in a statement that Nurofen specific pain range was launched into markets with an aim to help consumers to navigate their pain relief options.